Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.
Publication
, Journal Article
Liedtke, W; Limmroth, V
Published in: Ann Neurol
February 1996
Duke Scholars
Published In
Ann Neurol
DOI
ISSN
0364-5134
Publication Date
February 1996
Volume
39
Issue
2
Start / End Page
276 / 277
Location
United States
Related Subject Headings
- Treatment Outcome
- Neurology & Neurosurgery
- Multiple Sclerosis
- Magnetic Resonance Imaging
- Humans
- Clinical Trials, Phase II as Topic
- Brain
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Liedtke, W., & Limmroth, V. (1996). Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials. Ann Neurol, 39(2), 276–277. https://doi.org/10.1002/ana.410390221
Liedtke, W., and V. Limmroth. “Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.” Ann Neurol 39, no. 2 (February 1996): 276–77. https://doi.org/10.1002/ana.410390221.
Liedtke W, Limmroth V. Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials. Ann Neurol. 1996 Feb;39(2):276–7.
Liedtke, W., and V. Limmroth. “Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.” Ann Neurol, vol. 39, no. 2, Feb. 1996, pp. 276–77. Pubmed, doi:10.1002/ana.410390221.
Liedtke W, Limmroth V. Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials. Ann Neurol. 1996 Feb;39(2):276–277.
Published In
Ann Neurol
DOI
ISSN
0364-5134
Publication Date
February 1996
Volume
39
Issue
2
Start / End Page
276 / 277
Location
United States
Related Subject Headings
- Treatment Outcome
- Neurology & Neurosurgery
- Multiple Sclerosis
- Magnetic Resonance Imaging
- Humans
- Clinical Trials, Phase II as Topic
- Brain
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences